Jun 26, 2017 11:30 am UTC| Business
NEW YORK, June 26, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX), recapped clinical data from two triple combination therapy trials using TGR-1202 (umbralisib), the Company’s oral, next generation PI3K delta inhibitor and...
Strongbridge Biopharma plc Added to the Russell 3000® Index
Jun 26, 2017 11:30 am UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., June 26, 2017 -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Joe Tautges Appointed Chief Financial Officer for CDK Global
Jun 26, 2017 11:30 am UTC| Business
HOFFMAN ESTATES, Ill., June 26, 2017 -- CDK Global (Nasdaq:CDK) today announced that its Board of Directors has appointed Joe Tautges to serve as CDK’s new chief financial officer, effective August 9, 2017. Tautges...
Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program
Jun 26, 2017 11:30 am UTC| Business
Phase 1 results will inform potential Phase 2 studies in patients with fibromyalgia and neuropathic pain, planned to start in 2H17 Study includes single rising dose and multiple rising dose evaluations DEVON, Pa., June ...
Newly Published Nonclinical Data Highlight the Role of Olumacostat Glasaretil in Sebum Inhibition
Jun 26, 2017 11:30 am UTC| Business
MENLO PARK, Calif., June 26, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
Kura Oncology Added to Russell 3000® Index
Jun 26, 2017 11:30 am UTC| Business
LA JOLLA, Calif., June 26, 2017 -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it has been added to...
Jun 26, 2017 11:28 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 26, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...